| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/15/2005 | US20050204427 Expression vector comprising transcription regulatory protein for use in enhancing heterologous gene expression in plants |
| 09/15/2005 | US20050204424 for transgenic plants |
| 09/15/2005 | US20050204422 Using vector transformation to express antisense sequences which suppress phytoene desaturase activity and enhance phytoene concentration in plant |
| 09/15/2005 | US20050204421 Insecticidal protein; increasing resistance of plants to insects |
| 09/15/2005 | US20050204420 Biocidal protein |
| 09/15/2005 | US20050204419 Expression vector coding resistance polypeptide (RB) for use in transformation and geneation of disease resistant tomatoes and potatoes |
| 09/15/2005 | US20050204418 Genetically modified cereal plant having increased energy availability, dereased zein protein expression and enhanced globin protein concentration in grain/seeds |
| 09/15/2005 | US20050204415 Methods of blocking tissue destruction by autoreactive T cells |
| 09/15/2005 | US20050204414 Methods of blocking tissue destruction by autoreactive T cells |
| 09/15/2005 | US20050204413 Methods of blocking tissue destruction by autoreactive T cells |
| 09/15/2005 | US20050204412 Artery- and vein-specific proteins and uses therefor |
| 09/15/2005 | US20050204409 Gene for identifying individuals with familial dysautonomia |
| 09/15/2005 | US20050204407 Methods for identifying and developing compounds that interact with voltage-gated potassium channels of the kv4 family |
| 09/15/2005 | US20050203345 Articulating paddle elevator and arthroscopic method for using same |
| 09/15/2005 | US20050203289 Functional biopolymer modification reagents and uses thereof |
| 09/15/2005 | US20050203288 Amino acid sequences which suppress the activities of inhibitors of apoptosis proteins (IAPs); for use as tool in treatment of cell proliferative disorders |
| 09/15/2005 | US20050203285 Separating viral particle from solutions via variation in salt concentration |
| 09/15/2005 | US20050203284 a 15 to 22-residue polypeptide analog that forms an amphipathic alpha helix in the presence of lipids; anticholesterol agents; hypercholesterolemia, cardiovascular disorders, atherosclerosis, restenosis, hypertriglyceridemia, high density lipoprotein deficiency, metabolic disorders |
| 09/15/2005 | US20050203283 ISOFORMS OF NUCLEAR RECEPTOR RXR a |
| 09/15/2005 | US20050203282 For screening of agonists and antagonists of receptor which may have advantageous pharmaceutical or diagnostical properties; for identification of patients who may present genetic disorders induced by inactive receptor |
| 09/15/2005 | US20050203281 Generating insoluble matrices comprising immobilized nicotinic acetylcholine receptor (AChR) for use as tool in diagnosing myasthenia gravis; immunodiagnostics |
| 09/15/2005 | US20050203280 Nucleotide sequences coding gramnegative microorganismal genomic sequences for use as tool in diagnosing middle ear infection |
| 09/15/2005 | US20050203050 hKIS compositions and methods of use |
| 09/15/2005 | US20050203048 Human leucine-rich repeat containing protein expressed predominately in bone marrow, HLRRBM1 |
| 09/15/2005 | US20050203046 Modulating immune disorder or condition by administering an effective amount of an agonist or antagonist of IL-33 or IL-33 Receptor complex (IL-33R); modulates response to a number of immune and inflammatory conditions such as asthma, allergy, multiple sclerosis, inflammatory bowel disorder, arthritis |
| 09/15/2005 | US20050203036 Compositions and methods for treating hematologic malignancies and multiple drug resistance |
| 09/15/2005 | US20050203033 Identification and characterization of an anthocyanin mutant (ant1) in tomato |
| 09/15/2005 | US20050203026 Rosacea; vascular endothelial growth factor inhibitors; protease inhibitors such as Bowman-Birk Inhibitor, soybean trypsin inhibitor, and Eglin chymotrypsin inhibitor |
| 09/15/2005 | US20050203025 Compounds and methods for modulating nonclassical cadherin-mediated functions |
| 09/15/2005 | US20050203024 Peptides and methods for inducing cellular resistance to infection |
| 09/15/2005 | US20050203023 Use of rAFP inhibit or prevent apoptosis |
| 09/15/2005 | US20050203022 Type II TGF-beta receptor/immunoglobulin constant region fusion proteins |
| 09/15/2005 | US20050203021 Identifying prorenin modulators for treatment of cardiovascular and organ hypertrophy; enzyme inhibitors; mimetics; blood pressure; arterial thickening |
| 09/15/2005 | US20050203020 Safe drug administration carrier capable of extending the half life of a drug in the blood without the risk of contamination of viruses |
| 09/15/2005 | US20050203019 Pharmacoperones for correcting disease states involving protein misfolding |
| 09/15/2005 | US20050203018 Diagnosing hepatic disorders using aberrant growth hormone expression levels in liver |
| 09/15/2005 | US20050203015 Stable, water soluble; inhibitors of endothelial cell proliferation and of angiogenesis; tumors |
| 09/15/2005 | US20050203012 Human parathyroid hormone modifications, preparation and use |
| 09/15/2005 | US20050203010 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides |
| 09/15/2005 | US20050203009 Inhibiting VPAC1 (Vasoactive intestinal peptide)-mediated tumorigenesis; inhibits binding of pituitary adenylate cyclase-activating polypeptide (PACAP) to cell membranes |
| 09/15/2005 | US20050203007 Eglin c based drugs for treatment of disease |
| 09/15/2005 | US20050203004 Pharmacologically active polypeptide glycoconjugates |
| 09/15/2005 | US20050203003 Contulakin-G, analogs thereof and uses therefor |
| 09/15/2005 | US20050202544 Nucleotide sequences coding benzoic/anthranilic acid regulatory sequences in tandem; gene transfer vector for improving heterologous gene expression |
| 09/15/2005 | US20050202543 Method for producing L-amino acid |
| 09/15/2005 | US20050202538 Fc-erythropoietin fusion protein with improved pharmacokinetics |
| 09/15/2005 | US20050202537 Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins |
| 09/15/2005 | US20050202536 Nucleotide sequences comprising nucleotide sequences coding immune response modulator; immunotherapeutics; immunodiagnostics |
| 09/15/2005 | US20050202535 Fusion protein comprising bowman-kirk, soybean trypsin and eglin C inhibitors for use in treatment and prevention of inflammatory, arthritic and skin disorders |
| 09/15/2005 | US20050202532 Amino acid sequences for prevention and treatment of cardiovascular disease |
| 09/15/2005 | US20050202531 Receptor protein for identifying modulators to treat and prevent inflammatory, antherosclerotic and cancer disorders; wound healing agents |
| 09/15/2005 | US20050202530 Enhanced secretion of a polypeptide by a microorganism |
| 09/15/2005 | US20050202529 Humanised antibodies |
| 09/15/2005 | US20050202527 Fusion polypeptide comprising fibrinopeptide A, serine protease and thrombin-cleavable sequences for use in identifying modulators for prevention and treatment of thrombotic disorders; anticoagulants |
| 09/15/2005 | US20050202526 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/15/2005 | US20050202522 Using feast/famine regulatory proteins (FFRPs) as tool in screening for micobiocide and/or bactericides |
| 09/15/2005 | US20050202512 Immunoglobulins; libraries; antibodies; complementary determining regions; immunoassay |
| 09/15/2005 | US20050202499 Reagents and methods useful for detecting diseases of the breast |
| 09/15/2005 | US20050202498 Linkers that provide enhanced affinity and specificity to chimeric zinc finger proteins |
| 09/15/2005 | US20050202497 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/15/2005 | US20050202496 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/15/2005 | US20050202485 Hepatic specific tumor polypeptides; diagnosing cell proliferative disorders of liver |
| 09/15/2005 | US20050202482 CD38 splice variants and uses thereof |
| 09/15/2005 | US20050202481 Novel polypeptide ESDN, polynuleotides encoding the polypeptide, and utility of the polypeptide |
| 09/15/2005 | US20050202479 Methods and materials relating to insulin growth factor-like (IGFL) polypeptides and polynucleotides |
| 09/15/2005 | US20050202475 Using chimeric membrane protein as diagnostic/prognostic indicator of cell proliferative disorders |
| 09/15/2005 | US20050202472 Using long transient receptor potential channels (LTRPC2) as tools in identifying modulators for intracellular calcium concentration |
| 09/15/2005 | US20050202467 Nucleotide sequences coding serotonin receptor (5-HT1A receptor) for use in identifying modulators for prevntion and treatment of neuropsychiatric disorders |
| 09/15/2005 | US20050202462 Hepatic modulator for prevention and treatment of hepatic dysfunction, hepatitis and liver cancer |
| 09/15/2005 | US20050202454 "STRAP" and "STEAP"(six transmembrane (epithelial) antigen of the prostate) |
| 09/15/2005 | US20050202450 Polypeptides stable under hypoxic and nonhypoxic conditions; antihypoxic agents; myocardial necrosis and arrhythmia, strokes, autoimmune deseases, neurodegenerative disorders |
| 09/15/2005 | US20050202442 Novel therapeutic targets in cancer |
| 09/15/2005 | US20050202439 Mammalian membrane polypeptide for use in identifying modulators for prevention and treatment of urogenital disorders; contraceptives |
| 09/15/2005 | US20050202431 Coumpound for use in diagnosis and treatment of cell proliferative disorders; gene therapy; antitumor agents |
| 09/15/2005 | US20050202430 Nucleotide sequences coding extracellular matrix protein for use in treatment and prevention of cell proliferative disorders; promoting osteogenesis |
| 09/15/2005 | US20050202424 Membrane protein for use as tool in identifying modulators for treatment of phenotype-mediated antibiotic-resistance; microbiocides; bactericides; preventing infection in cystic fibrosis patients |
| 09/15/2005 | US20050202422 Novel nucleic acids and polypeptides |
| 09/15/2005 | US20050202420 Oligonucleotides or pna oligomers and a method for detecting the methylation state of genomic dna in a parallel manner |
| 09/15/2005 | US20050202418 HCV peptide compositions |
| 09/15/2005 | US20050202415 Coronavirus amino acid sequences for use in prevention and treatment of infection and cell proliferative disorders |
| 09/15/2005 | US20050202413 nucleic acid encoding an immunoreactive peptide not recognized by antibodies which are directed against other herpes-viruses for accurate diagnosis; test kits |
| 09/15/2005 | US20050202403 Yeast cells expressing modified G proteins and methods of use therefor |
| 09/15/2005 | US20050202398 Use of biological photoreceptors as directly light-activated ion channels |
| 09/15/2005 | US20050202048 Chlamydia antigens and vaccine uses of the protein |
| 09/15/2005 | US20050202046 Canine vaccine for protection against ehrlichiosis |
| 09/15/2005 | US20050202044 A fusion protein containing an antigen of an influenza virus and a bacterial stress protein; vaccines induce a cytolytic T-cell (CTL) response in a mammal |
| 09/15/2005 | US20050202043 Multimerised HIV fusion inhibitors |
| 09/15/2005 | US20050202042 Toxin B repeating units (rBRU) of Clostridium difficile and an antigen of a pathogenic microorganism other than C. difficile; eliciting T-cell dependent and antibody responses |
| 09/15/2005 | US20050202039 Renibacterium salmoninarum vaccine |
| 09/15/2005 | US20050202037 Group a streptococcal vaccines |
| 09/15/2005 | US20050202036 Alternate reading frame polypeptides drived from hepatitis C and methods of their use |
| 09/15/2005 | US20050202035 Stress protein complex; a grp170 polypeptide and an immunogenic polypeptide; antitumor |
| 09/15/2005 | US20050202034 polypeptide relating to the autoimmune disease pemphigus vulgaris |
| 09/15/2005 | US20050202033 Heat shock protein-based vaccines and immunotherapies |
| 09/15/2005 | US20050202032 Use of neglected target tissue antigens in modulation of immune responses |
| 09/15/2005 | US20050202031 Immunoglobulin specific to insect hydrolase for use in treatment and prevention of animal hyperimmune response to flea exposure; biological control agent |
| 09/15/2005 | US20050202027 Multivalent compounds for crosslinking receptors and uses thereof |
| 09/15/2005 | US20050202026 Introducing into a first plant an expression vector containing a nucleotide sequence encoding the protection protein operably linked to a transcriptional promoter, introducing into a second plant an expression vector, crossing first plant and second plant to produce offspring, selecting transgenic plant |
| 09/15/2005 | US20050202019 Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis |
| 09/15/2005 | US20050202017 Assay; contacting a test compound with a HB-954 polypeptide; determining whether the test compound binds to the G protein-coupled receptor |